v3.26.1
INVESTMENT IN CONDUIT PHARMACEUTICALS (Details Narrative)
9 Months Ended
May 31, 2025
USD ($)
May 19, 2025
Jan. 22, 2025
Sep. 30, 2025
USD ($)
Mar. 31, 2026
USD ($)
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Mar. 31, 2025
shares
Jan. 24, 2025
$ / shares
shares
Dec. 31, 2024
USD ($)
shares
Apr. 22, 2024
shares
Equity securities         $ 5,885 $ 3,900     $ 206,177  
Reverse stock split   1-for-10                
Reverse Stock Split [Member]                    
Stockholders equity note stock split, conversion ratio   10 100              
Conduit Pharmaceuticals Inc [Member]                    
Equity securities         5,885 3,900        
Conduit Pharmaceuticals Inc [Member]                    
Investment owned | shares                   4,015,250
Equity securities         $ 5,885 $ 3,900     $ 200,000  
Reverse stock split     1-for-100              
Conduit Pharmaceuticals Inc [Member] | CDT Common Stock [Member]                    
Proceeds from sale, maturity and collection of investments       $ 13,990            
Conduit Pharmaceuticals Inc [Member]                    
Investment owned | shares           29,445   29,445 2,944,514  
Equity securities                 $ 3,900  
Investment owned, fraction share payout | $ / shares               $ 0.63    
Equity securities                 $ 200,000  
Conduit Pharmaceuticals Inc [Member] | CDT Common Stock [Member]                    
Investment owned, fraction share payout | $ / shares           $ 0.63        
Proceeds from sale, maturity and collection of investments $ 13,990                  
Conduit Pharmaceuticals Inc [Member] | CDTTW Warrants [Member]                    
Investment owned | shares         709,000 709,000     709,000  
Conduit Pharmaceuticals Inc [Member] | Private Warrants [Member]                    
Investment owned | shares                 540,000  
Class of warrant or right, number of securities | shares           540,000 540,000